- Er:YAG Laser - Technology Made in Germany For more than 35 years, - - PowerPoint PPT Presentation

er yag laser technology made in germany
SMART_READER_LITE
LIVE PREVIEW

- Er:YAG Laser - Technology Made in Germany For more than 35 years, - - PowerPoint PPT Presentation

MCL31 Dermablate - Er:YAG Laser - Technology Made in Germany For more than 35 years, Asclepion has been operating on the medical laser market. As the company is based in Jena, famous through the world as the global center of the optics


slide-1
SLIDE 1

MCL31 Dermablate

  • Er:YAG Laser -
slide-2
SLIDE 2

MCL31 100 1116 EN 2

For more than 35 years, Asclepion has been operating on the medical laser

  • market. As the company is based in Jena, famous through the world as the

global center of the optics industry since 1846, the company owes it success to the steady development of new technologies and the active collaboration with researchers from German universities and industries.

  • More than 35 years experience in the aesthetic laser medicine and surgery
  • Development, production, service & training center in Jena
  • TOP100 of the most innovative medium-sized businesses in Germany

Technology „Made in Germany“

slide-3
SLIDE 3

MCL31 100 1116 EN 3

The first Er:YAG laser for dermatology was introduced in 1995 by Asclepion. Now we present the sixth generation for dermatological and aesthetic laser medicine – stronger, faster, more efficient, flexible: MCL31 Dermablate.

MCL29 Dermablate Dermablate D1 DermaStar MCL30 Dermablate Dermablate Effect Milestones of product introduction of Er:YAG laser

The sixth generation of the Dermablate series

slide-4
SLIDE 4

MCL31 100 1116 EN 4

Laser: Er:YAG, class 4 Wavelength: 2,940 nm Energy:

  • Max. 2.5 J

Fluence:

  • Max. 250 J/cm²

Pulse duration: 100 – 1000 µs Frequency: 1 – 20 Hz Modes: Ablation, Therm, MicroSpot, Gyn* Spot size Ablation: 1 – 6 mm (Vario) 8 – 12 mm (Vario XL*) Spot size MicroSpot*: 13x13mm with variable skin coverage rate of 10 – 25% Spot size Gyn*: V-Spot with 90° reflecting gold-coated mirror V-Spot with 360° reflecting gold-coated cone Dimensions: 36 x 60 x 93 cm (W x D x H) Weight:

  • Approx. 75 Kg

* Optional * Available with the Juliet upgrade

All specifications are subject to change without notice.

Specifications

slide-5
SLIDE 5

MCL31 100 1116 EN 5

Clinical success

  • 1990: first clinical trials by R. Kaufmann et al.
  • 1996: MCL29 Dermablate was the first Er:YAG

laser in dermatology introduced by Aesculap- Meditec (Asclepion), more than 800 systems worldwide Germany: The Dermablate has became a standard tool for dermatologists in the treatment of a wide range of coetaneous lesions

  • more than 20 years experience

USPs

  • integrated suction system
  • VarioTEAM technology
  • MicroSpot technology
  • variable coverage and pulse length
  • Sub-ablative mode (coagulation mode)
  • sterilizable distance holder
  • most homogeneous beam profile
  • thermal mode
  • unbeaten reliability, fast amortization
  • Footswitch for adjusting the fluence

Clinical success and USPs

slide-6
SLIDE 6

MCL31 100 1116 EN 6

Advantages of the Er:YAG laser and handpiece technology Ablativ (VarioTEAM)

  • precise and safe ablation
  • very limited thermal damage (necrotic zone 30µm/70µm)
  • superficial treatments possible as well as deep ablation
  • reduced risk of scarring and pigmentation changes
  • many treatments require no anaesthesia
  • short healing process, little side effects

Fractional (MicroSpot)

  • integrated smoke evacuation
  • new designed and patented handpiece
  • automatic suction and lens cleaning
  • cooling outlets integrated in distance holders
  • maintenance free
  • Microlens technology with 169 fractional spots per shot
  • up to 20 Hz (quickest fractional technology available)

Er:YAG vs. CO2

slide-7
SLIDE 7

MCL31 100 1116 EN 7

  • integrated smoke evacuation
  • suction directly at the treatment area
  • activation by footswitch for reduced noise pollution
  • more powerful smoke evacuation*
  • up to 50% quieter smoke evacuation (-6dB)*
  • handpiece with patented TEAM technology

(Total Evacuation of Ablated Material)

  • easy change of filters

Triple filter system

HEPA filter (High Efficiency Particulate Air filter) Active coal – filter Pre-filter

* compared to the previous model MCL30 Dermablate

Integrated filter system

slide-8
SLIDE 8

MCL31 100 1116 EN 8

VarioTEAM handpiece (Ablation) with TEAM-Technology (Total Evacuation of Ablated Material)  very effective smoke evacuation  lowest smell nuisance  no assistance necessary  cost reduction  patents: US 6 162 218 DE 197 106 76 with VarioSpot-Technology  spot size from 1 to 6 mm adjustable in 1mm steps  spot size from 8 to 12 mm adjustable in 2mm steps  automatic spot size detection  automatic fluence adaption

VarioTEAM handpiece with variable spot size

VarioTEAM handpiece

slide-9
SLIDE 9

MCL31 100 1116 EN 9

MicroSpot handpiece (Fractional) with MicroSpot-Technology  use of stable and precise microlens array technology  integrated smoke evacuation (TEAM-Technology)  air cooling adaptable (e.g. cooling from Zimmer)  very flexible adjustment of ablation depth through fluence  very flexible adjustment of cover rate through variable coverage of 10 to 25%  controlled thermal effect with selectable pulse duration MAZ* MAZ* MAZ*

EPIDERMIS DERMIS

* MAZ = Microscopic ablation zone by Dr. Bettina A. Buhren & Dr. Peter A. Gerber, Clinic of Dermatology, Dusseldorf, Germany

Micro-lens array MicroSpot output Laser beam input

MicroSpot handpiece

slide-10
SLIDE 10

MCL31 100 1116 EN 10

Flat-Top beam profile

most homogeneous spot Ablation Fractional

Beam profile

slide-11
SLIDE 11

MCL31 100 1116 EN 11

Classical Skin Resurfacing with VarioTEAM handpiece Almost 100% of the epidermal layer will be completely removed (Depth of ablation is variable).

  • > accordingly long wound healing

Fractional treatment with MicroSpot handpiece Only 10-25% of the epidermal layer will be completely removed (depth of ablation is variable).

  • > fast wound healing, supported by the untreated skin

Ablation vs. Fractional

slide-12
SLIDE 12

MCL31 100 1116 EN 12

Linear correlation

  • constant ablation depth of 5 µm per

1 J/cm² (above ablation threshold)

  • The higher the FLUENCE,

the more skin will be removed. Thermal Mode

  • Specs: 1 J/cm², 20 Hz, N = 5 ... 
  • coagulation zone up to 400 µm depth

(with single impulse up to 40 µm) Ablation in µm Fluence in J/cm2

Ablation vs. Fluence

  • different mechanism of Er:YAG -

Ablation vs. Coagulation

slide-13
SLIDE 13

MCL31 100 1116 EN 13

5 10 15 20 25 30 125 250 375 500 625 750 875 1000

Coagulation depth µm as function of pulse length µs

 Ablation: increased visibility in the treatment area, thanks to less bleeding  Fractional: thermal effect for skin tightening

Ablation vs. Coagulation

slide-14
SLIDE 14

MCL31 100 1116 EN 14

MicroSpot: Flexibility combined with effectiveness

unique results thanks to variability of the cover rate and pulse length Setting E10% N10% N25% C10% W25%

Mode Expert Normal Normal Cold Warm Spot number 169 Size pattern 13 x 13 mm2 Energy per pulse (J) 1.6 J 0.8 J 2.0 J 0.6 J 2.0 J Fluence per pulse 10 5 5 4 4 Cover rate 10% 10% 25% 10% 25% Pulse length (µs) 300 300 300 100 1,000 Recommended pulses 2-3 3-4 3-4 4 4

Ablation vs. Coagulation

slide-15
SLIDE 15

MCL31 100 1116 EN 15

Modes Settings Purpose

Ablation Fluence, pulse length, Frequency, spot size* Ablation Therm Fluence, pulse number, time between pulses (interval), spot size* Thermal MicroSpot Fluence, pulse length, time between pulses (interval), coverage** Fractional TOOLS Pilot beam brightness, background colors, pulse rate, filter usage etc. Defaults

* Spot size is set directly on the handpiece ** Coverage is set directly on the handpiece

Easy to use

  • clear menu navigation
  • touch-sensitive display
  • different background colors selectable

Display

slide-16
SLIDE 16

MCL31 100 1116 EN 16

Modern design

  • elegant
  • mobile
  • space saving
  • ergonomic handpieces
  • balanced spring articulated mirror arm
  • articulated mirror arm with a long range (110cm)*
  • footswitch for adjusting the fluence

* Arm about 25% longer than the previous model MCL30 Dermablate

Design

slide-17
SLIDE 17

MCL31 100 1116 EN 17

0.0001 0.001 0.01 0.1 1 10 100 1000 10000 100000

100 1000 10000

Wavelength [nm] Absorption Coefficient [cm-1]

4000 3000 2000 5000 500 400 300 200

Melanin Protein Water Scattering Desoxy-Hemoglobin Oxy-Hemoglobin

High absorption in water Low absorption in melanin and hemoglobin Selective thermolysis (effective targeting and low side effects)

Selective absorption

slide-18
SLIDE 18

MCL31 100 1116 EN 18

  • Removal of dermal and epidermal lesions:

epidermal naevi, Keratosis seborrhoeic, warts, naevus cell naevus, hypertrophic scars, acne scars, xanthelasma, rhinophyma, wrinkles, Lentigines, actinic Keratosis, Syringomas

  • Full skin resurfacing
  • Soft laser peel
  • Skin refreshing
  • Fractional laser therapy

Smoothes fine lines, wrinkles and rhytids; perfectly blends uneven pigmentation; minimizes the size of pores; dramatically clears photo-damaged skin; fills in acne scars

Indications

slide-19
SLIDE 19

MCL31 100 1116 EN 19

Indications | Dermablation

slide-20
SLIDE 20

MCL31 100 1116 EN 20

By courtesy of Dr. Said Hilton & Heike Heise, Medical Skin Center, Dr. Hilton & Partners, Dusseldorf, Germany

Indications | Dermal nevus

slide-21
SLIDE 21

MCL31 100 1116 EN 21

By courtesy of Dr. R. Hartmann, Blaustein, Germany

Indications | Epidermal nevus

slide-22
SLIDE 22

MCL31 100 1116 EN 22

By courtesy of Dr. Klaus-Peter Koch, Harsefeld, Germany

Indications | Fibro adenoma

slide-23
SLIDE 23

MCL31 100 1116 EN 23

Parameters: 2 mm Spot, 18 J/cm2, 10 Hz

By courtesy of Dr. Peter Arne Gerber, Clinic of Dermatology, Dusseldorf, Germany

Indications | Xanthelasma

slide-24
SLIDE 24

MCL31 100 1116 EN 24

KTP-Laser (532 nm)

Parameters: 2 mm Spot 18 J/cm2 10 Hz

By courtesy of Dr. Peter Arne Gerber, Clinic of Dermatology, Dusseldorf, Germany

Indications | Xanthelasma

slide-25
SLIDE 25

MCL31 100 1116 EN 25

Parameters: 2 mm Spot, 18 J/cm2, 10 Hz

By courtesy of Dr. Peter Arne Gerber, Clinic of Dermatology, Dusseldorf, Germany

Indications | Verruca Seborrhoica

slide-26
SLIDE 26

MCL31 100 1116 EN 26

By courtesy of Dr. Said Hilton & Heike Heise, Medical Skin Center, Dr. Hilton & Partners, Dusseldorf, Germany

Indications | Lentigo senilis

slide-27
SLIDE 27

MCL31 100 1116 EN 27

3 weeks after treatment By courtesy of Dr. Paul Wood, Proderma, Bad Homburg, Germany

Indications | Keratosis Seborrhoica

slide-28
SLIDE 28

MCL31 100 1116 EN 28

By courtesy of Dr. Said Hilton & Heike Heise, Medical Skin Center, Dr. Hilton & Partners, Dusseldorf, Germany

Indications | Fibroma

slide-29
SLIDE 29

MCL31 100 1116 EN 29

6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany

Indications | Verruca Seborrhoica Pigmentosa

slide-30
SLIDE 30

MCL31 100 1116 EN 30

6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany

Indications | Verruca Seborrhoica Pigmentosa

slide-31
SLIDE 31

MCL31 100 1116 EN 31

6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany

Indications | Dermal NCN

slide-32
SLIDE 32

MCL31 100 1116 EN 32

By courtesy of Dr. M. Fuchs, Dr. Samimi-Fard, Germany

Indications | Milia

slide-33
SLIDE 33

MCL31 100 1116 EN 33

By courtesy of Dr. R. Hartmann, Blaustein, Germany

Indications | Syringoma

slide-34
SLIDE 34

MCL31 100 1116 EN 34

By courtesy of D. Fleming, M.D., Brisbane, Australia

Indications | Freckles

slide-35
SLIDE 35

MCL31 100 1116 EN 35

By courtesy of D. Fleming, M.D., Brisbane, Australia

Indications | Full skin resurfacing

slide-36
SLIDE 36

MCL31 100 1116 EN 36

Indications | Fractional laser therapy

slide-37
SLIDE 37

MCL31 100 1116 EN 37

immediately after

  • ne day after

two days after three days after

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

Indications | Fractional laser therapy

slide-38
SLIDE 38

MCL31 100 1116 EN 38

By courtesy of Dr. Said Hilton & Heike Heise, Medical Skin Center, Dr. Hilton & Partners, Dusseldorf, Germany

Indications | Fractional laser therapy

slide-39
SLIDE 39

MCL31 100 1116 EN 39

pre op after 4 weeks

Acne scars and sun damage

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

Indications | Fractional laser therapy

slide-40
SLIDE 40

MCL31 100 1116 EN 40

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

Indications | Fractional laser therapy

slide-41
SLIDE 41

MCL31 100 1116 EN 41

By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

Indications | Fractional laser therapy

slide-42
SLIDE 42

MCL31 100 1116 EN 42

Single treatment, 20 J/cm2, 10 % cover rate, 3 shots on the same fractional spots, 3 and 7 days By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

Indications | Fractional laser therapy

slide-43
SLIDE 43

MCL31 100 1116 EN 43

Periorbital treatment only (forehead): single treatment, 20 J/cm2, 10 % cover rate, 3 shots on the same fractional spots, 3 and 7 days By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

Indications | Fractional laser therapy

slide-44
SLIDE 44

MCL31 100 1116 EN 44

Result after 5 treatments By courtesy of Dr. Gerd G. Gauglitz, Dermatology of LMU Munich, Germany

Indications | Fractional laser therapy

slide-45
SLIDE 45

MCL31 100 1116 EN 45

Result after 4 treatments By courtesy of Dr. Gerd G. Gauglitz, Dermatology of LMU Munich, Germany

Indications | Fractional laser therapy

slide-46
SLIDE 46

MCL31 100 1116 EN 46

Striae after 5 treatments By courtesy of Dr. Gerd G. Gauglitz, Dermatology of LMU Munich, Germany

Indications | Fractional laser therapy

slide-47
SLIDE 47

MCL31 100 1116 EN 47

before after 3 treatments By courtesy of Prof. Kabir Sardana, Delhi

Indications | Fractional laser therapy

slide-48
SLIDE 48

MCL31 100 1116 EN 48

before after 2 treatments By courtesy of Prof. Kabir Sardana, Delhi

Indications | Fractional laser therapy

slide-49
SLIDE 49

MCL31 100 1116 EN 49

before after 3 treatments By courtesy of Prof. Kabir Sardana, Delhi

Indications | Fractional laser therapy

slide-50
SLIDE 50

MCL31 100 1116 EN 50

Dermal lesions

  • 1. Khatri KA. Ablation of coetaneous lesions using an Erbium:YAG laser. J Cosmet Laser Ther 2003; 5:1-4
  • 2. Kaufmann R, Beier C. Erbium YAG laser therapy of skin lesions. Med Laser Appl 2001;16:252-263
  • 3. Doi H, Ogawa Y, Hatoko M. Treatment of melanin-induced benign dermal lesions by an Erbium-YAG laser system. J Plast

Reprod Surg 2000; 0:90-95

  • 4. Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratosis by Er:YAG laser. J Cutan Laser Ther

2001;3:63-66

  • 5. Beier C, Kaufmann R. Efficacy of Erbium:YAG laser ablation in Darer disease and Hailey-Hailey disease. Arch Dermatol. 1999;

135(4):378-80

  • 6. Gerd G. Gauglitz, Markus Reinholz, Peter Kaudewitz, Jürgen Schauber, Thomas Ruzicka. Treatment of Striae Distensae Using

an Ablative Erbium-Yag Fractional Laser versus a 585-nm Pulsed-Dye Laser. J Cosmet Laser Ther. 2014 Jun;16(3):117-9. doi: 10.3109/14764172.2013.854621. Epub 2013 Nov 18. Aesthetic lesions (Skin Resurfacing)

  • 1. Jasin ME. Achieving superior resurfacing results with the Erbium:YAG laser. Arch Facial Plast Surg 2002; 4:262-266
  • 2. Perez MI, Bank DE. Facial skin resurfacing with the Erbium:YAG laser: new findings. Cosmetic Dermatology 1998;5:27-37
  • 3. Khatri KA, Machado A, Magro C, Davenport S. Laser peel: facial rejuvenation with a superficial Erbium:YAG laser treatment.

J Coetaneous Laser Ther 2000;2:119-123

  • 4. Khatri KA, Ross V, Grevelink JM, Magro CM, Andersson RR. Comparison of Erbium:YAG and carbon dioxide lasers in

resurfacing of facial rhytids. Arch Dermatol 1999;135(4):391-7

  • 5. Jeffrey S. Orringer, MD, Laure Rittie´, PhD, Ted Hamilton, MS, Darius J. Karimipour, MD, John J. Voorhees, MD, FRCP, and

Gary J. Fisher, PhD. Intraepidermal Erbium:YAG laser resurfacing: Impact on the dermal matrix

  • 6. Karsai S, Czarnecka A, Jünger M, Raulin C. Ablative Fractional Lasers (CO2 and Er:YAG): A Randomized Controlled Double-

Blind Split-Face Trial of the Treatment of Peri-Orbital Rhytids. Lasers Surg Med 2010;42:160-167

  • 7. Karsai S, Raulin C. Comparison of Clinical Outcome Parameters, the Patient Benefit Index (PBI-k) and Patient Satisfaction

After Ablative Fractional Laser Treatment of Peri-Orbital Rhytids. Lasers in Surgery and Medicine 42:215–223 (2010)

  • 8. Daniel Cassuto, MD, Milan, Italy. Fractional Er:YAG (Dermablate) Histological in vivo study

Bibliography | Er:YAG-Laser

slide-51
SLIDE 51

www.asclepion.com